Depression in Chronic Pain Populations

Depression is common in people with chronic pain, with prevalence rates around 39-40% for clinically significant symptoms, far higher than in the general population. This co‑occurrence worsens pain intensity, disability, and treatment outcomes, but addressing it as part of integrated pain care can improve function and quality of life.[1][2][3]

HOW COMMON IS DEPRESSION IN CHRONIC PAIN?

Large systematic reviews show that approximately 40% of adults with chronic pain experience clinically significant depression, and rates are even higher in pain clinics (up to 50-60%). Conditions such as fibromyalgia, neuropathic pain, and spinal pain

have particularly high rates, with younger adults, women, and those with nociplastic (central sensitisation) pain at greatest risk. About 37% meet criteria for major depressive disorder, compared to around 10% in the community.[3][4][1]

WHY DEPRESSION AND CHRONIC PAIN OFTEN OCCUR TOGETHER

Chronic pain and depression share overlapping brain circuits, neurotransmitters (such as serotonin and noradrenaline), and inflammatory pathways. Pain can contribute to depression through sleep disruption, reduced activity, social withdrawal, and feelings of hopelessness, while depression can amplify pain by increasing threat perception, reducing pain inhibition, and lowering motivation for self‑care. Risk factors include trauma history, genetic vulnerability, and persistent pain despite treatment.[2][5]

HOW DEPRESSION AFFECTS CHRONIC PAIN

In people with chronic pain:

  • Depression is linked to higher pain intensity, more widespread pain, and greater pain interference with daily life.[4][5][1]

  • Functional disability is more severe, with reduced work participation, social engagement, and self‑management ability.[1][2][4]

  • Treatment response is poorer, including less benefit from physical therapies, medications, and procedures.[5][2]

  • Healthcare use increases, with more visits, investigations, and medications.[2][4]

Depression does not cause pain but acts as an amplifier that makes pain harder to manage.[5]

RECOGNISING DEPRESSION IN CHRONIC PAIN

Symptoms of depression in chronic pain can overlap with pain effects, such as fatigue, poor concentration, and sleep problems, making it easy to overlook. Key signs include:[2][5]

  • Persistent low mood, loss of interest or pleasure in activities.

  • Feelings of worthlessness, excessive guilt, or hopelessness about pain recovery.

  • Changes in appetite, weight, or suicidal thoughts (which are more common in this group).

Routine screening with tools like the PHQ‑9 is recommended in pain settings to identify treatable depression.[3][1]

TREATMENT APPROACHES

Effective management involves integrated care addressing both pain and depression, rather than treating them separately.[5][2]

PSYCHOLOGICAL THERAPIES

  • Cognitive‑behavioural therapy (CBT) adapted for pain and depression improves mood, coping, and function.

  • Behavioural activation to gradually increase valued activities despite pain.

  • Acceptance and commitment therapy to build psychological flexibility.[2][5]

MEDICATIONS

  • Antidepressants such as SNRIs (e.g. duloxetine) or TCAs that treat both pain and depression.

  • Careful optimisation with GP or psychiatrist input.[5]

MULTIDISCIPLINARY PAIN PROGRAMS

Combine education, exercise, psychological support, and medication review for better outcomes than pain treatment alone.[2][5]

SELF‑MANAGEMENT

• Regular physical activity, sleep hygiene, social connection, and mindfulness practices.[2]

Early recognition and treatment of depression can reduce pain burden and improve daily functioning for people with chronic pain.[1][5][2]

FOR REFERENCES (1) - SCROLL DOWN

WHICH TREATMENTS WORK FOR BOTH CHRONIC PAIN AND DEPRESSION

Several treatments show evidence for benefiting both chronic pain and depression by targeting overlapping brain pathways involved in mood, pain amplification, and stress response. These include certain medications, psychological therapies, and lifestyle approaches, often most effective when combined in multidisciplinary care.

MEDICATIONS WITH DUAL BENEFITS

  • SNRIs (serotonin-norepinephrine reuptake inhibitors): Duloxetine and venlafaxine are first-line options, with strong evidence for reducing pain in conditions like neuropathic pain, fibromyalgia, and low back pain while also improving depressive symptoms. Duloxetine (60-120 mg/day) has moderate-certainty evidence from meta-analyses for both pain relief and depression remission.[1][2]

  • TCAs (tricyclic antidepressants): Amitriptyline and nortriptyline are highly effective for neuropathic pain (NNT ~3.6 for 50% relief) and depression, often at lower doses for pain (10-50 mg). Nortriptyline has a better tolerability profile with less sedation.[3][1]

  • Other antidepressants: Some SSRIs like escitalopram may help milder depression but have weaker pain effects compared to SNRIs or TCAs.[1]

These work by enhancing descending pain-inhibitory pathways (noradrenaline/serotonin) and modulating mood circuits.

PSYCHOLOGICAL THERAPIES

  • Cognitive-behavioural therapy (CBT): Adapted CBT for pain and depression improves pain coping, reduces catastrophising, and alleviates depressive symptoms, with effects comparable to antidepressants in some studies.[4]

  • Acceptance and commitment therapy (ACT): Helps build psychological flexibility, reducing pain interference and depressive rumination.

  • Combination therapies: CBT plus antidepressants or fear-avoidance physical therapy shows superior outcomes for pain, function, and mood in chronic back pain with high depression.[5]

EXERCISE AND PHYSICAL ACTIVITY

Graded aerobic and strength exercise (e.g. walking, swimming) reduces pain sensitivity, improves function, and lifts mood via endorphin release, neuroplasticity, and reduced inflammation. Meta-analyses confirm benefits for both fibromyalgia pain and major depression.

MULTIDISCIPLINARY APPROACHES

Integrated programs combining medication, therapy, exercise, and education yield the best results, with 75-80% showing mood improvements and 40% gaining in pain/function. These address the bidirectional cycle without relying solely on opioids.[5]

Consult a clinician to tailor options, as individual responses vary. SNRIs like duloxetine are often a strong starting point due to their evidence base and tolerability.[2][1]

FOR REFERENCES (2) - SCROLL DOWN

REFERENCES (1)

REFERENCES (2)

Dr. Jeremy Tannenbaum

Dr Jeremy Tannenbaum is a dual-qualified Specialist Pain Medicine Physician and Specialist Psychiatrist based in Perth, Western Australia. He provides evidence-based assessment and management of chronic and complex pain conditions, including neuropathic pain, musculoskeletal pain, injury-related pain, and pain associated with psychological and sleep factors. His unique training across both Pain Medicine and Psychiatry allows him to take an integrated approach to understanding pain and helping patients improve function, wellbeing, and quality of life.

Qualifications: BSc, MBBS (Hons), FRANZCP, FFPMANZCA

https://www.drjeremytannenbaum.com.au/about
Previous
Previous

Developmental Trauma and Chronic Pain

Next
Next

Fibromyalgia and Central Sensitisation